$CTOR
Citius Oncology, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Cranford, NJ
CTOR chart
What traders are saying about $CTOR
Latest postsCitius Oncology, Inc. news
- Citius Oncology, Inc. (CTOR) Stock Price & News
Syfe ·
- Citius Pharmaceuticals Reports LYMPHIR Quality-of-Life Improvements in Study 302
TipRanks ·
- Citius Oncology Reports Quality-of-Life Improvements in LYMPHIR Study 302
TradingView ·
- Citius Oncology's Positive Quality of Life Data for LYMPHIR® (denileukin diftitox-cxdl) in Relapsed or Refractory Cutaneous T-Cell Lymphoma Presented at Premier Global CLTG Congress in Europe
Yahoo Finance ·
- Earnings Calendar for:
Yahoo Finance ·
- Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026
Yahoo Finance ·
- Citius Pharmaceuticals to Participate in October 2026 Investor Conferences
Yahoo Finance ·
- Citius Pharmaceuticals to Participate in September 2026 Investor Conferences
Yahoo Finance ·
- Citius Oncology shares tumble as Q3 revenue misses forecasts despite LYMPHIR launch momentum
investorshub.advfn.com ·
- Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri
Yahoo Finance ·
Citius Oncology, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$24.8M | -$21.1M | $2.4M | $380,811 |
| Diluted EPS | $-0.34 | $-0.31 | $0.27 | $0.12 |
| Total assets (year end) | $110.0M | $90.5M | $72.6M | $68.2M |
| Cash and equivalents (year end) | $7.3M | – | – | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Citius Oncology, Inc.
- Ticker
- CTOR (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cranford, NJ
- Incorporated in
- DE
- Fiscal year end
- September 30
- SEC CIK
- 1851484
- Former names
- TenX Keane Acquisition
Frequently asked questions
What exchange is Citius Oncology, Inc. listed on?
Citius Oncology, Inc. trades on the Nasdaq under the ticker symbol CTOR.
What industry is Citius Oncology, Inc. in?
Citius Oncology, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Citius Oncology, Inc. headquartered?
Citius Oncology, Inc.'s business address on file with the SEC is in Cranford, NJ.
When does Citius Oncology, Inc.'s fiscal year end?
Citius Oncology, Inc.'s fiscal year ends on September 30.